Thiard News@F4F

@newsen.bsky.social

3 days ago

Bioretec Ltd Announces New Rights Issue to Raise EUR 14.8 Million for Growth Strategy Bioretec Ltd is set to launch a rights issue aiming to raise approximately EUR 14.8 million. The funds will advance their innovative medical device strategies and product development efforts.

Bioretec Ltd Announces New Rights Issue to Raise EUR 14.8 Million for Growth Strategy #RemeOs™ #Bioretec #Finland #Helsinki #Medical_Device

Thiard News@F4F

@newsen.bsky.social

3 days ago

Bioretec Announces Major Rights Issue for EUR 14.8 Million to Strengthen Capital Base Bioretec Ltd plans a rights issue to raise up to EUR 14.8 million for capital enhancement. This initiative aims to bolster expansion in key markets, particularly the U.S.

Bioretec Announces Major Rights Issue for EUR 14.8 Million to Strengthen Capital Base #Bioretec #Finland #Helsinki #RemeOs #capital_increase

Thiard News@F4F

@newsen.bsky.social

3 days ago

Bioretec Ltd's Extraordinary General Meeting Resolutions Highlight Strategic Growth Plans Bioretec Ltd's extraordinary general meeting introduced key resolutions, including plans for a rights offer and strategic share issuance.

Bioretec Ltd's Extraordinary General Meeting Resolutions Highlight Strategic Growth Plans #Bioretec #Finland #Helsinki #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 days ago

Stephen Industries Receives Exemption from Finnish Takeover Bid Laws by Financial Supervisory Authority The Finnish Financial Supervisory Authority has approved a permanent exemption for Stephen Industries Inc Oy from mandatory public takeover bid requirements, impacting Bioretec Ltd's upcoming rights issue.

Stephen Industries Receives Exemption from Finnish Takeover Bid Laws by Financial Supervisory Authority #Bioretec #Finland #Helsinki #Kustaa_Poutiainen #Stephen_Industries

Thiard News@F4F

@newsen.bsky.social

6 days ago

Bioretec Adjusts Publication Date for January-March 2026 Business Review to May 15, 2026 Bioretec Ltd has rescheduled its Business Review for January-March 2026 to May 15, 2026, a day later than originally announced.

Bioretec Adjusts Publication Date for January-March 2026 Business Review to May 15, 2026 #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

6 days ago

Bioretec Announces Revised Publication Date for 2026 Business Review Document Bioretec Ltd has officially changed the publication date of its January-March 2026 Business Review to May 15, 2026, from the earlier announced date.

Bioretec Announces Revised Publication Date for 2026 Business Review Document #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Bioretec Ltd Unveils Its 2025 Financial Results and Annual Report with Recent Innovations Bioretec Ltd has published its 2025 Financial Statements and Annual Report, highlighting innovative biodegradable implant technologies in orthopedic care.

Bioretec Ltd Unveils Its 2025 Financial Results and Annual Report with Recent Innovations #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Bioretec Ltd Unveils Its Financial Statements and Annual Report for 2025 Bioretec Ltd has released its Financial Statements and Annual Report for the year 2025, showcasing innovations in orthopedic technologies and growth in the market.

Bioretec Ltd Unveils Its Financial Statements and Annual Report for 2025 #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Timo Lehtonen Transitions to Advisory Role at Bioretec After Leadership Period Timo Lehtonen steps down as CTO of Bioretec to become an External Executive Advisor, continuing to influence the company’s technology strategy.

Timo Lehtonen Transitions to Advisory Role at Bioretec After Leadership Period #Bioretec #Finland #Tampere #technology_strategy #Timo_Lehtonen

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Timo Lehtonen Transitions to External Executive Advisor at Bioretec Timo Lehtonen, the former CTO of Bioretec, shifts to External Executive Advisor role, continuing his support for the company’s technology and strategy.

Timo Lehtonen Transitions to External Executive Advisor at Bioretec #Bioretec #Finland #Tampere #Timo_Lehtonen #External_Advisor

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Bioretec Ltd to Launch Major Rights Issue to Strengthen Financial Position Bioretec Ltd is set to initiate a significant rights issue aimed at raising between EUR 5 million and EUR 15 million to bolster its financial stability and support its business growth plans.

Bioretec Ltd to Launch Major Rights Issue to Strengthen Financial Position #Bioretec #Finland #Helsinki #RemeOs #Stephen_Industries

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Bioretec Ltd Announces Extraordinary General Meeting to Discuss Shareholder Rights Offering Bioretec Ltd invites shareholders to an Extraordinary General Meeting set for March 27, 2026, to discuss key proposals, including a rights offering.

Bioretec Ltd Announces Extraordinary General Meeting to Discuss Shareholder Rights Offering #Bioretec #Finland #Rights_Offering #Helsinki #General_Meeting

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec Ltd Considers Rights Issue to Strengthen Capital and Support New Strategy Bioretec Ltd's Board is evaluating a potential rights issue to enhance capital resources as it pursues a new strategy aimed at growth.

Bioretec Ltd Considers Rights Issue to Strengthen Capital and Support New Strategy #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec's Financial Transformation: A Year of Strategic Renewal and Growth In 2025, Bioretec embarked on a transformative journey to restructure and enhance its business model, focusing on core technologies and expanding market presence.

Bioretec's Financial Transformation: A Year of Strategic Renewal and Growth #Bioretec #Finland #Tampere #Growth_Strategy #RemeOs

Thiard News@F4F

@newsen.bsky.social

1 month ago

Bioretec's Financial Year 2025: A Focused Approach to Rebuilding and Growth Bioretec Ltd reflects on a transformative 2025, focusing on rebuilding and aligning its strategies for sustainable growth and market expansion.

Bioretec's Financial Year 2025: A Focused Approach to Rebuilding and Growth #Bioretec #RemeOs #absorbable_implants

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bioretec Ltd. Proposals from Shareholders' Nomination Board Ahead of 2026 Annual Meeting The Shareholders' Nomination Board of Bioretec Ltd has put forward proposals for board member elections and remuneration for the upcoming 2026 Annual General Meeting.

Bioretec Ltd. Proposals from Shareholders' Nomination Board Ahead of 2026 Annual Meeting #Bioretec #Finland #Tampere #Annual_Meeting #Board_Members

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bioretec's Transition to Absorbable Orthopedic Implants and TPT Status Bioretec Ltd has achieved Transitional Pass-Through Payment status for its RemeOs Trauma Screw, revolutionizing absorbable orthopedic implants.

Bioretec's Transition to Absorbable Orthopedic Implants and TPT Status #Bioretec #Trauma_Screw #Finland #Tampere #RemeOs

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bioretec Receives Transitional Pass-Through Payment for RemeOs Trauma Screw Bioretec Ltd has been awarded TPT status for its RemeOs Trauma Screw, enhancing access to innovative orthopedic technology and optimizing patient care.

Bioretec Receives Transitional Pass-Through Payment for RemeOs Trauma Screw #Bioretec #Finland #Tampere #RemeOs #TPT_Status

Thiard News@F4F

@newsen.bsky.social

2 months ago

Bioretec Welcomes Tuukka Paavola as New CFO to Lead Financial Strategy Tuukka Paavola has been appointed as Chief Financial Officer of Bioretec, bringing 20 years of financial expertise to the innovative orthopedic implant company.

Bioretec Welcomes Tuukka Paavola as New CFO to Lead Financial Strategy #Bioretec #Finland #Tampere #CFO #Tuukka_Paavola

Thiard News@F4F

@newsen.bsky.social

2 months ago

Tuukka Paavola Takes the Helm as CFO of Bioretec to Drive Financial Strategies Bioretec, a leader in absorbable orthopedic implants, welcomes Tuukka Paavola as CFO. His extensive finance experience will shape the company's growth.

Tuukka Paavola Takes the Helm as CFO of Bioretec to Drive Financial Strategies #Bioretec #Finland #Tampere #Orthopedic_Implants #Tuukka_Paavola

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec Ltd Unveils Financial Reporting Schedule and Annual General Meeting Details for 2026 Bioretec Ltd has announced its schedule for financial reporting in 2026 along with important details about its Annual General Meeting planned for May.

Bioretec Ltd Unveils Financial Reporting Schedule and Annual General Meeting Details for 2026 #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec Ltd Unveils Financial Reporting Schedule and AGM for 2026 Bioretec Ltd outlines key dates for its financial reports and Annual General Meeting in 2026, highlighting advancements in orthopedic care.

Bioretec Ltd Unveils Financial Reporting Schedule and AGM for 2026 #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec's Bold Strategic Overhaul: Paving the Way to 2028 Success Bioretec Ltd unveils its updated strategy for 2026-2028, targeting sales growth and innovation with ambitious financial goals to shape the future of orthopedic implants.

Bioretec's Bold Strategic Overhaul: Paving the Way to 2028 Success #Bioretec #Finland #Tampere #Orthopedic_Implants #RemeOs

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec's New Strategy for 2026-2028: Aiming for Growth and Innovation in Orthopedics Bioretec Ltd has unveiled its ambitious strategy for 2026-2028, focusing on commercialization and innovation in biodegradable implants. New financial targets were also set.

Bioretec's New Strategy for 2026-2028: Aiming for Growth and Innovation in Orthopedics #RemeOs™ #Bioretec #Finland #Tampere #Activa

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec Receives FDA Breakthrough Designation for RemeOs™ DrillPin: A New Hope for Fracture Treatment Bioretec Oy has been awarded FDA Breakthrough Device Designation for its biodegradable RemeOs™ DrillPin, aiming to revolutionize fracture treatment. This innovative technology targets both pediatric and adult patients.

Bioretec Receives FDA Breakthrough Designation for RemeOs™ DrillPin: A New Hope for Fracture Treatment #RemeOs™ #Bioretec #Finland #Tampere #FDA_Approval

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec's RemeOs™ DrillPin Receives FDA Breakthrough Device Designation Bioretec Oy has announced that its RemeOs™ DrillPin has received FDA Breakthrough Device Designation, enhancing its orthopedic product line.

Bioretec's RemeOs™ DrillPin Receives FDA Breakthrough Device Designation #RemeOs™ #Bioretec #Finland #Tampere #FDA

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec Concludes Change Negotiations to Enhance Competitiveness and Profitability Bioretec announces the conclusion of change negotiations aimed at streamlining operations, impacting staff and promising annual cost savings in Finland.

Bioretec Concludes Change Negotiations to Enhance Competitiveness and Profitability #Bioretec #Finland #Tampere #orthopedic_care #RemeOs

Thiard News@F4F

@newsen.bsky.social

3 months ago

Bioretec Completes Statutory Change Negotiations and Reorganization Plans Bioretec has concluded statutory negotiations to enhance its competitiveness and profitability, impacting employee roles and restructuring operations.

Bioretec Completes Statutory Change Negotiations and Reorganization Plans #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec Ltd's Business Review: Strategy and Growth from January to September 2025 This article reviews Bioretec Ltd's performance and strategic adjustments in the first nine months of 2025, highlighting key developments and financial results.

Bioretec Ltd's Business Review: Strategy and Growth from January to September 2025 #Bioretec #Finland #Tampere #RemeOs #Activa

Thiard News@F4F

@newsen.bsky.social

4 months ago

Bioretec Ltd's Strategic Review for 2025: A Focus on Growth and Development in Orthopedic Solutions Bioretec Ltd's business review outlines its performance and future strategy from January to September 2025, highlighting significant changes in leadership and approach.

Bioretec Ltd's Strategic Review for 2025: A Focus on Growth and Development in Orthopedic Solutions #Bioretec #Finland #Tampere #RemeOs #Activa